title: Reply to the letter to the editor: does the use of ultrasound affect contamination of musculoskeletal injections sites?
authors.affiliation: MedStar Georgetown Orthopaedic Institute, Georgetown University Hospital, 3800 Reservoir Road, PHC Floor 1, Washington, DC, 20007, USA, Thomas.i.sherman@gmail.com.
authors.forename: Thomas
authors.initials: T
authors.lastname: Sherman
authors.forename: Joseph
authors.initials: J
authors.lastname: Ferguson
authors.forename: William
authors.initials: W
authors.lastname: Davis
authors.forename: Matthew
authors.initials: M
authors.lastname: Russo
authors.forename: Evan
authors.initials: E
authors.lastname: Argintar
mesh_terms: D001419:Bacteria / Q000187:drug effects*; D003428:Cross Infection / Q000517:prevention & control*; D004202:Disinfectants / Q000627:therapeutic use*; D004203:Disinfection / Q000379:methods*; D004866:Equipment Contamination / Q000517:prevention & control*; D006801:Humans; D007270:Injections, Intra-Articular / Q000009:adverse effects*; D012867:Skin / Q000187:drug effects*; D018084:Ultrasonography, Interventional / Q000009:adverse effects*
chemical_list: D004202:Disinfectants